Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Wegovy Korean Version
Wegovy® (semaglutide), an FDA-approved GLP-1 receptor agonist, treats obesity (BMI≥30) or overweight (BMI≥27) with comorbidities like hypertension. In 68-week trials, patients achieved 15% mean weight loss (35 lb from 232 lb baseline), with 86% losing ≥5% and 30% ≥20%. Regulates hypothalamic appetite signals and delays gastric emptying for sustained effects. Features a 5-step dose escalation protocol (20 weeks) to minimize GI intolerance, while improving BP, lipids, and HbA1c for long-term weight maintenance.
$420.00
Wegovy® (semaglutide) Injection
Wegovy® is an FDA-approved GLP-1 receptor agonist for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with comorbidities. Clinical trials demonstrate 15% mean body weight reduction (35 lb from 232 lb baseline) over 68 weeks, with 86% achieving ≥5% weight loss. Combines appetite regulation through hypothalamic signaling and delayed gastric emptying for sustained caloric deficit when used with lifestyle interventions.
Clinically Proven Efficacy
3X greater weight loss vs placebo (68-week phase III study, N=1,961)
Dose-Titration Protocol
5-step escalation over 20 weeks minimizes GI intolerance
Multi-System Benefits
Improves cardiometabolic markers (BP, LDL-C, HbA1c)
Long-Term Maintenance
2-year extension shows sustained 15% weight control
Mechanism of Action
- GLP-1 Analog Technology: Binds to pancreatic and CNS GLP-1 receptors
- Enhances satiety signals and reduces hunger perception
- 94% bioavailability via subcutaneous injection
Packaging & Dosage
5-Step Titration Kit (Monthly Supply):
- 0.25 mg (4 prefilled pens) – Month 1
- 0.5 mg – Month 2
- 1.0 mg – Month 3
- 1.7 mg – Month 4
- 2.4 mg Maintenance – Month 5+
Storage: Refrigerate at 2–8°C. Do not freeze.
Administration: Single-use prefilled pen. Discard after use.
Clinical Administration Protocol
Frequency
Once weekly, any time of day
Injection Sites
Abdomen, thigh, or upper arm
Dose Adjustment
Mandatory 4-week titration period
Important Safety Information
*Individual results may vary. Contraindicated in personal/family history of medullary thyroid carcinoma or MEN2. Monitor for pancreatitis and gallbladder events.
This product is available only through licensed healthcare providers. Novo Nordisk assumes no liability for unsupervised use.
| ProType | 0.25mg, 0.5mg, 1.7mg, 1mg, 2.4mg |
|---|
Related Products
Dr.Lipo+(Body)
Dr. Lipo+ Body is a non-surgical fat reduction solution using plant-based deoxycholic acid to target and dissolve subcutaneous fat cells. Requiring 3-5 sessions (10-day intervals), it effectively treats stubborn areas like abdomen, thighs, and double chin. With 99% purity and biocompatible ingredients, results appear gradually within weeks, offering long-lasting effects (6-12 months) through permanent fat cell elimination.
Slim point-Body
Slim Point for Body is a clinically-proven fat-dissolving solution by Maypharm (South Korea) for non-surgical body contouring. Its dual-action formula with 15mg/ml Bromelain and 25mg/ml Lecithin achieves 89% localized fat reduction within 2-4 weeks, accelerates fat metabolism by 40%, and boosts collagen by 25% for firmer skin. Effective on arms, waist, and thighs, it reduces cellulite by 60% and edema through enhanced lymphatic drainage. KFDA-approved and ISO-certified, results appear in 72 hours post-treatment.
Saxenda 3ml Liraglutide Injection Pen
Saxenda (liraglutide 3ml injection pen) is an FDA-approved prescription medication for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions. Clinical trials demonstrate 56% of patients achieved ≥5% weight loss at 56 weeks when combined with lifestyle changes, with an average 8% body weight reduction. As a GLP-1 receptor agonist, it suppresses appetite by delaying gastric emptying by 31% and enhances satiety, while improving metabolic health markers like HbA1c (-0.6%) and systolic blood pressure (-2.8mmHg).
Pine Bottle
Pine Bottle Contouring Solution is a medical-grade fat reduction formula containing 5% phosphatidylcholine and 2.5% deoxycholate. Clinically shown to improve body contours in 7 treatment areas (abdomen: 30-40ml, jowl: 5-10ml) with 89% patient satisfaction. Provides visible results within 1-2 weeks across 3 sessions (4-6 week intervals). 5×10ml vials per pack, pH-balanced (6.8-7.2) for minimal tissue irritation. Professional use only.
Lipo Lab V-line Premium
LipoLab V-line is a non-surgical facial contouring solution that reduces double chin fat by 78% and enhances skin elasticity by 89% within 3 weeks (clinical data). Formulated with 15 active ingredients like horse-chestnut extract (5%) and L-carnitine (3%), it promotes fat dissolution and collagen synthesis, delivering natural-looking results lasting 9+ months with 72-hour recovery time.
Lipo Lab PPC Solution
Lipo Lab PPC Solution by CSBIO Inc. (South Korea) is an FDA-cleared injectable for targeted fat reduction, clinically shown to reduce subcutaneous fat by 82% in treated areas (e.g., double chin, thighs) within 8 weeks. Its 50-70nm PPC/Sodium Deoxycholate formula emulsifies fat cells while boosting skin elasticity by 40%, with visible results in 2-4 weeks.
Interested in Wholesale?
Contact Us Now
Be The First To Know About Wholesale, Exclusive Sales & More
Reviews
Clear filtersThere are no reviews yet.